ENT & Allergy – Q1 2022 Acquisition Activity and Outlook May 5, 2022
ENT & Allergy Deal Activity Cools Off to Begin 2022 Look For Additional PE Investor Interest Ahead
The first quarter of 2022 delivered two reported ENT practice acquisitions, coming down from a flurry of deal activity to end last year.